miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

Chemotherapy is one of the options for cancer treatment. FOLFOX is one of the widely used chemotherapeutic regimens used to treat primarily colorectal cancer and other cancers as well. However, the emergence of chemo-resistance clones during cancer treatment has become a critical challenge in the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hon, Kha Wai, Abu, Nadiah, Ab Mutalib, Nurul-Syakima, Jamal, Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088237/
https://www.ncbi.nlm.nih.gov/pubmed/30127741
http://dx.doi.org/10.3389/fphar.2018.00846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088237/
https://www.ncbi.nlm.nih.gov/pubmed/30127741
http://dx.doi.org/10.3389/fphar.2018.00846

Ejemplares similares